Close Menu

NEW YORK (GenomeWeb) – Consumer wellness startup Onegevity Health said today that it is incorporating Gencove's low-pass genome sequencing and analytics into its service.

Under the partnership, Gencove, a spinout from the New York Genome Center, will provide its low-pass sequencing solution to Onegevity's multi-omic artificial intelligence platform and services. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.